AAS
REGN icon

Ameritas Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Ameritas Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-54
Closed -$30.4K – 1842
2025
Q3 		$30.4K Sell
54
-31
-36% -$17.5K ﹤0.01% 1275
2025
Q2 		$44.7K Buy
+85
New +$47.4K ﹤0.01% 1362
2024
Q4 		– Sell
-373
Closed -$392K – 917
2024
Q3 		$392K Sell
373
-8
-2% -$8.9K 0.02% 607
2024
Q2 		$400K Buy
381
+5
+1% +$4.85K 0.02% 648
2024
Q1 		$357K Sell
376
-32
-8% -$30.4K 0.01% 655
2023
Q4 		$371K Buy
408
+126
+45% +$104K 0.02% 498
2023
Q3 		$233K Buy
+282
New +$222K 0.01% 704
2023
Q2 		– Sell
-268
Closed -$216K – 2089
2023
Q1 		$216K Sell
268
-24
-8% -$18.1K 0.01% 742
2022
Q4 		$211K Sell
292
-6
-2% -$4.43K 0.01% 809
2022
Q3 		$205K Buy
+298
New +$188K 0.01% 706
2022
Q2 		– Sell
-416
Closed -$291K – 848
2022
Q1 		$291K Buy
416
+86
+26% +$54.4K 0.01% 671
2021
Q4 		$208K Buy
+330
New +$203K 0.01% 767

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ameritas Advisory Services's REGN Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 54 shares — an estimated $30.4K sold.

Ameritas Advisory Services first reported a position in REGN in Q4 2021 and held it in 12 quarters. The position peaked at $400K in Q2 2024. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 54 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $30.4K.
  • Ameritas Advisory Services first reported a position in Regeneron Pharmaceuticals in Q4 2021 and held it in 12 quarters.
  • Ameritas Advisory Services's Regeneron Pharmaceuticals position peaked at $400K in Q2 2024.
  • 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.